All News | FDA

Advertising & Promotion

Jul 5, 2023
Final Guidance on Quantitative Efficacy and Risk Info in DTC Promotions Is Little Changed From Draft
Jun 29, 2023
Ex-DePuy Sales Rep Charged With Defrauding Hospital, Lying to FBI About Sterilization Interference
Jun 28, 2023
Connecticut To Require Companies With Sale Reps To Register
Jun 13, 2023
OPDP Issues First Enforcement Letter in a Year
Jun 6, 2023
FDA Proposes One-Page Patient Medication Information Notice
May 21, 2023
Study Finds Responses to Drug Ads May Be ‘Overly Optimistic’ Without Disclosures
May 17, 2023
Court Grants Summary Judgment to Device Company Accused of Wrongful Discharge of Sales Rep Over Off-label Marketing
May 2, 2023
OPDP Researchers Move Ahead With Three Studies
Apr 25, 2023
OPDP Researchers Plan Survey on How Consumers Interpret Specific Quantitative Claims
Apr 20, 2023
Court: State Law Claims Involving Class II Device Cleared via De Novo Process Not Expressly Preempted

Good Clinical Practice

Oct 18, 2023
CDER Seeks Opinions on Innovative Trial Approaches
Oct 7, 2023
Two Investigators Receive Warning Letters Over Trial Concerns
Sep 26, 2023
FDA Offers Recommendations on How To Deal With Major Trial Disruptions
Sep 20, 2023
CVM Offers Informed Consent Guidance
Sep 13, 2023
What Should IRBs Consider in Reviewing Individual Expanded Access Submissions?
Sep 6, 2023
Clinical Investigator Receives Warning Letter Over Alleged Failure To Follow Protocol
Aug 29, 2023
HHS Issues Draft Scientific Integrity Policy
Aug 21, 2023
FDA Releases Long-Awaited Final Informed Consent Guidance
Aug 6, 2023
WHO Proposes Clinical Trial Best Practices
Jul 31, 2023
SACHRP Makes Recommendations on Draft FDA DCT and OHRP Limited IRB Review Guidances, Adds New Members

U.S. Food Labeling

Feb 16,2023
USDA Strengthens Enforcement of Organic Rules
Feb 2,2023
FDA Seeks Input on Designing FOP Labeling System
Jan 19,2023
FSIS Rule Expands List of Products Qualifying for Generic Label Approval
Jan 5,2023
FDA, FSIS Set Food Labeling Uniform Compliance Date
Jan 5,2023
FDA Removes Stay on Yogurt Standard of Identity Provisions
Dec 30,2022
FTC Expands Advertising Guide To Include All Health-Related Claims
Dec 22,2022
Agencies Jointly Issue RFI for Input on Regulating Biotechnology
Dec 9,2022
FDA Posts Clarifying Guidances on Food Allergen Labeling, Asks for Comments on 'Milk,' 'Eggs'
Nov 23,2022
Cell Culture Food Gets First FDA Safety Go-Ahead
Nov 10,2022
Court Enjoins Distribution of Adulterated, Misbranded Supplements

FDA Regulation & Enforcement

Jun 20, 2025
Congress Introduces Bills To Ban DTC Drug Ads
Jun 18, 2025
DOJ Revises Policy on Foreign Corrupt Practices Act Enforcement, With a Focus on U.S. Interests
Jun 14, 2025
OPDP Warning Letter Alleges Instagram Post Lacked Risk Info
Jun 11, 2025
HHS OIG: FDA Must Address Gaps in Domestic Food Facility Inspections
Jun 6, 2025
Study Finds Increased Consumer Use of Nutrition Facts Labels
Jun 4, 2025
Consent Decree Allows Evaluation of Company’s Claims That Products Are Devices, Not Unapproved Drugs
May 30, 2025
Senator Questions FDA’s Commitment to DTC Oversight
May 30, 2025
Pa. Legislature Considers Food Labeling Bills
May 26, 2025
Physicians Ask Supreme Court To Review Decision Allowing FDA To Regulate Stem Cell Procedure
May 23, 2025
OPDP Issues First Warning Letter in Nearly Two Years

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.